MarketPeel
Insider Trading Intelligence
Pricing
…
SG

Sydney A. Gilman

DMAC
VP, REGULATORY AFFAIRS · DIAMEDICA THERAPEUTICS INC. · CIK 0001793016
FILING MIX · LIFETIME100%/0%
BUYS
2
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
25,000
AVG SELL PX
—
TRADE KIND
SHOWING 2 / 2
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Sydney A. Gilman. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
DMAC · 25,000 shares · as of Jul 28, 2021
06,25012,50018,75025,0002021SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
FLOW · 2 buys / 0 sellsCOVERAGE · 6 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
DMAC
DIAMEDICA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
25,000——25,000Jul 28, 2021Jul 29, 2021 ↗View →
DMAC
DIAMEDICA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
17,500——17,500Jun 1, 2020Jun 2, 2020 ↗View →
Other insiders · DMAC
Loading peer insiders…
About this filer
CIK 0001793016
ROLE
VP, Regulatory Affairs
PRIMARY
DMAC
COMPANIES
1
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001793016DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback